Huemer, F.; Weiss, L.; Regitnig, P.; Winder, T.; Hartmann, B.; Thaler, J.; Piringer, G.; Schmitt, C.A.; Eisterer, W.; Gänzer, H.;
et al. Local and Central Evaluation of HER2 Positivity and Clinical Outcome in Advanced Gastric and Gastroesophageal Cancer—Results from the AGMT GASTRIC-5 Registry. J. Clin. Med. 2020, 9, 935.
https://doi.org/10.3390/jcm9040935
AMA Style
Huemer F, Weiss L, Regitnig P, Winder T, Hartmann B, Thaler J, Piringer G, Schmitt CA, Eisterer W, Gänzer H,
et al. Local and Central Evaluation of HER2 Positivity and Clinical Outcome in Advanced Gastric and Gastroesophageal Cancer—Results from the AGMT GASTRIC-5 Registry. Journal of Clinical Medicine. 2020; 9(4):935.
https://doi.org/10.3390/jcm9040935
Chicago/Turabian Style
Huemer, Florian, Lukas Weiss, Peter Regitnig, Thomas Winder, Bernd Hartmann, Josef Thaler, Gudrun Piringer, Clemens A. Schmitt, Wolfgang Eisterer, Hannes Gänzer,
and et al. 2020. "Local and Central Evaluation of HER2 Positivity and Clinical Outcome in Advanced Gastric and Gastroesophageal Cancer—Results from the AGMT GASTRIC-5 Registry" Journal of Clinical Medicine 9, no. 4: 935.
https://doi.org/10.3390/jcm9040935
APA Style
Huemer, F., Weiss, L., Regitnig, P., Winder, T., Hartmann, B., Thaler, J., Piringer, G., Schmitt, C. A., Eisterer, W., Gänzer, H., Wüstner, A., Andel, J., Jagdt, B., Ulmer, H., Greil, R., & Wöll, E.
(2020). Local and Central Evaluation of HER2 Positivity and Clinical Outcome in Advanced Gastric and Gastroesophageal Cancer—Results from the AGMT GASTRIC-5 Registry. Journal of Clinical Medicine, 9(4), 935.
https://doi.org/10.3390/jcm9040935